Centiva Capital’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-19,150
| Closed | -$360K | – | 1186 |
|
|
2023
Q1 | $360K | Buy |
+19,150
| New | +$360K | 0.01% | 619 |
|
|
2021
Q2 | – | Sell |
-67,674
| Closed | -$1.75M | – | 1032 |
|
|
2021
Q1 | $1.75M | Buy |
67,674
+56,992
| +534% | +$1.47M | 0.07% | 79 |
|
|
2020
Q4 | $571K | Sell |
10,682
-2,474
| -19% | -$132K | 0.02% | 268 |
|
|
2020
Q3 | $543K | Buy |
13,156
+1,662
| +14% | +$68.6K | 0.04% | 207 |
|
|
2020
Q2 | $557K | Buy |
+11,494
| New | +$557K | 0.03% | 153 |
|